{"id":7432,"date":"2026-04-28T11:20:53","date_gmt":"2026-04-28T03:20:53","guid":{"rendered":"https:\/\/witology.com.tw\/daily-biohealth\/2026-04-28\/"},"modified":"2026-04-28T12:05:09","modified_gmt":"2026-04-28T04:05:09","slug":"9-48","status":"publish","type":"page","link":"https:\/\/witology.com.tw\/en\/daily-biohealth\/9-48\/","title":{"rendered":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-04-28\uff5cIntellia \u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u7b2c\u4e09\u671f\u6578"},"content":{"rendered":"\n<style>.wit-daily {\n  --bg:#0f0e0c;--bg2:#16140f;--fg:#e8e3d8;--dim:#8a8276;--mute:#5a5448;\n  --card:#1a1816;--card2:#221f1b;--bdr:#3a342e;--bdr2:#4a423a;\n  --acc:#c4b09a;--acc2:#d4a574;--acc3:#7a6e62;\n  --tw:#e07a6a;--us:#7ab3d4;\n  --up:#8fc78a;--dn:#d97070;--nu:#9a9282;\n  --warn:#d4a574;\n  --line-h:1.85;\n}\n.wit-daily * {margin:0;padding:0;box-sizing:border-box}\n.wit-daily {background:var(--bg)}\n.wit-daily {font-family:\"Noto Sans TC\",sans-serif;background:var(--bg);color:var(--fg);line-height:var(--line-h);-webkit-font-smoothing:antialiased;background-image:radial-gradient(ellipse 80% 40% at 50% 0%,rgba(196,176,154,.06),transparent 70%)}\n.wit-daily .wrap {max-width:860px;margin:0 auto;padding:40px 22px 80px}\n.wit-daily .hdr {text-align:center;padding:64px 0 48px;margin-bottom:48px;border-bottom:1px solid var(--bdr)}\n.wit-daily .hdr-date {font-size:12px;letter-spacing:8px;color:var(--acc);text-transform:uppercase;margin-bottom:14px;font-weight:500}\n.wit-daily .hdr h1 {font-family:\"Noto Serif TC\",serif;font-size:clamp(30px,5vw,46px);font-weight:700;letter-spacing:3px;margin-bottom:12px;background:linear-gradient(135deg,var(--fg) 0%,var(--acc) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text}\n.wit-daily .hdr-sub {font-size:13px;color:var(--dim);letter-spacing:1px}\n.wit-daily .stats {margin-bottom:48px}\n.wit-daily .st {display:flex;align-items:center;gap:12px;margin-bottom:8px}\n.wit-daily .st-bar {height:3px;border-radius:2px;min-width:3px;transition:width .5s;opacity:.85}\n.wit-daily .st-lb {font-size:13px;flex:1;color:var(--fg)}\n.wit-daily .st-ct {font-size:12px;color:var(--dim);min-width:24px;text-align:right;font-variant-numeric:tabular-nums}\n.wit-daily .lbl {font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;color:var(--fg);margin-bottom:28px;padding-bottom:12px;border-bottom:2px solid var(--acc);letter-spacing:1px}\n.wit-daily .c {background:var(--card);border:1px solid var(--bdr);border-radius:4px;margin-bottom:36px;overflow:hidden;box-shadow:0 4px 24px rgba(0,0,0,.35),0 1px 0 rgba(196,176,154,.05) inset;backdrop-filter:blur(16px)}\n.wit-daily .c-hd {display:flex;justify-content:space-between;align-items:center;padding:22px 30px 0}\n.wit-daily .c-cat {font-size:10px;font-weight:700;letter-spacing:3px;text-transform:uppercase;color:var(--cc,var(--acc));border:1px solid var(--cc,var(--acc));padding:3px 12px;border-radius:2px;background:rgba(0,0,0,.2)}\n.wit-daily .c-snt {font-size:13px;font-weight:600;letter-spacing:.5px}\n.wit-daily .s-up {color:var(--up)}\n.wit-daily .s-dn {color:var(--dn)}\n.wit-daily .s-nu {color:var(--nu)}\n.wit-daily .c-t {padding:14px 30px 4px;font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;line-height:1.45;letter-spacing:.5px}\n.wit-daily .c-t a {color:var(--fg);text-decoration:none;transition:color .25s}\n.wit-daily .c-t a:hover {color:var(--acc2)}\n.wit-daily .c-src {padding:0 30px 14px;font-size:12px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .c-hype {display:flex;align-items:center;gap:14px;padding:10px 30px 14px;border-top:1px dashed var(--bdr);border-bottom:1px dashed var(--bdr);background:rgba(196,176,154,.03)}\n.wit-daily .c-hype-lb {font-size:10px;letter-spacing:2px;text-transform:uppercase;color:var(--dim);font-weight:700}\n.wit-daily .c-hype-dots {font-size:14px;color:var(--acc2);letter-spacing:3px;font-family:monospace}\n.wit-daily .c-hype-tx {font-size:12px;color:var(--acc);font-weight:500}\n.wit-daily .c-stocks {padding:14px 30px 18px;display:flex;flex-wrap:wrap;gap:6px}\n.wit-daily .stk {display:inline-flex;align-items:center;gap:4px;font-size:12px;padding:4px 12px;border-radius:2px;font-weight:500}\n.wit-daily .stk b {font-weight:700}\n.wit-daily .stk-tw {background:rgba(224,122,106,.12);color:var(--tw);border:1px solid rgba(224,122,106,.35)}\n.wit-daily .stk-us {background:rgba(122,179,212,.12);color:var(--us);border:1px solid rgba(122,179,212,.35)}\n.wit-daily .stk-other {background:rgba(255,255,255,.04);color:var(--dim);border:1px solid var(--bdr2)}\n.wit-daily .chg {font-size:11px;font-weight:600;padding:1px 6px;border-radius:2px;margin-left:2px}\n.wit-daily .chg-up {background:rgba(226,100,80,.20);color:#ff8f78}\n.wit-daily .chg-down {background:rgba(94,181,141,.20);color:#7ed0a6}\n.wit-daily .chg-flat {background:rgba(255,255,255,.06);color:var(--dim)}\n.wit-daily .c-img {width:100%;height:auto;aspect-ratio:1170\/540;object-fit:cover;border-top:1px solid var(--bdr);border-bottom:1px solid var(--bdr);filter:brightness(.92);display:block}\n.wit-daily .c-analysis {display:grid;grid-template-columns:1fr 1fr;border-top:1px solid var(--bdr)}\n.wit-daily .c-sec {padding:22px 30px;border-bottom:1px solid var(--bdr)}\n.wit-daily .c-sec:nth-child(odd) {border-right:1px solid var(--bdr)}\n.wit-daily .c-wide {grid-column:1\/-1;border-right:none !important}\n.wit-daily .c-sec h4 {font-size:14px;letter-spacing:2px;text-transform:uppercase;color:var(--acc);margin-bottom:12px;font-weight:700}\n.wit-daily .c-sec p {font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92}\n.wit-daily .c-counter {background:rgba(212,165,116,.05)}\n.wit-daily .c-counter h4 {color:var(--warn)}\n.wit-daily .c-counter blockquote {border-left:3px solid var(--warn);padding:6px 0 6px 16px;font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92;font-style:italic;margin:0}\n.wit-daily .c-watch {background:rgba(196,176,154,.04)}\n.wit-daily .c-watch-grid {display:grid;grid-template-columns:1fr 1fr 1fr;gap:18px;margin-top:6px}\n.wit-daily .c-watch-col {}\n.wit-daily .c-watch-h {font-size:12px;font-weight:700;color:var(--fg);margin-bottom:10px;padding-bottom:6px;border-bottom:1px solid var(--bdr2);display:flex;flex-direction:column;gap:2px}\n.wit-daily .c-watch-h span {font-size:10px;color:var(--dim);letter-spacing:1px;font-weight:400}\n.wit-daily .c-w-short {border-bottom-color:var(--dn)}\n.wit-daily .c-w-mid {border-bottom-color:var(--acc2)}\n.wit-daily .c-w-long {border-bottom-color:var(--up)}\n.wit-daily .c-watch-col ul {list-style:none;padding:0;margin:0}\n.wit-daily .c-watch-col li {font-size:13px;line-height:1.7;color:var(--fg);opacity:.88;padding:6px 0 6px 16px;position:relative}\n.wit-daily .c-watch-col li:before {content:\"\u25b8\";position:absolute;left:0;color:var(--acc);font-size:12px}\n.wit-daily .c-faqs {background:rgba(122,179,212,.04)}\n.wit-daily .c-faqs h4 {color:var(--us)}\n.wit-daily .c-faq-item {border-bottom:1px solid var(--bdr);padding:10px 0}\n.wit-daily .c-faq-item:last-child {border-bottom:none}\n.wit-daily .c-faq-item summary {cursor:pointer;font-size:14px;font-weight:600;color:var(--fg);padding:6px 0;list-style:none;display:flex;align-items:center;gap:10px;transition:color .2s}\n.wit-daily .c-faq-item summary::before {content:\"+\";color:var(--us);font-weight:700;font-size:18px;width:14px;display:inline-block;transition:transform .2s}\n.wit-daily .c-faq-item[open] summary::before {content:\"\u2212\"}\n.wit-daily .c-faq-item summary:hover {color:var(--acc2)}\n.wit-daily .c-faq-item p {font-size:13px;line-height:1.8;color:var(--fg);opacity:.85;padding:8px 0 6px 24px;margin:0}\n.wit-daily .c-ft {padding:16px 30px;border-top:1px solid var(--bdr);text-align:right;background:rgba(0,0,0,.15)}\n.wit-daily .c-ft a {font-size:13px;color:var(--acc);text-decoration:none;font-weight:500;transition:color .25s;letter-spacing:.5px}\n.wit-daily .c-ft a:hover {color:var(--acc2)}\n.wit-daily .briefs {background:var(--card);border:1px solid var(--bdr);border-radius:4px;padding:8px 0;margin-bottom:48px;box-shadow:0 2px 12px rgba(0,0,0,.25)}\n.wit-daily .b-item {display:flex;gap:12px;padding:12px 26px;border-bottom:1px solid var(--bdr);align-items:flex-start}\n.wit-daily .b-item:last-child {border-bottom:none}\n.wit-daily .b-dot {width:7px;height:7px;border-radius:50%;margin-top:9px;flex-shrink:0;box-shadow:0 0 8px currentColor}\n.wit-daily .b-link {color:var(--fg);text-decoration:none;font-size:14px;transition:color .25s;display:block;margin-bottom:2px;line-height:1.6}\n.wit-daily .b-link:hover {color:var(--acc2)}\n.wit-daily .b-meta {font-size:11px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .ftr {text-align:center;padding:36px 0;font-size:11px;color:var(--mute);border-top:1px solid var(--bdr);margin-top:24px;letter-spacing:1px}\n@media(max-width:680px) {.wit-daily .c-analysis {grid-template-columns:1fr}\n.wit-daily .c-sec:nth-child(odd) {border-right:none}\n.wit-daily .c-wide {grid-column:1}\n.wit-daily .c-t {font-size:19px;padding:12px 20px 4px}\n.wit-daily .c-hd, .wit-daily .c-src, .wit-daily .c-stocks, .wit-daily .c-sec, .wit-daily .c-ft, .wit-daily .c-hype {padding-left:20px;padding-right:20px}\n.wit-daily .c-watch-grid {grid-template-columns:1fr;gap:14px}}\n\/* \u5168\u57df(\u975e scoped):\u50c5\u8a72\u7522\u696d\u65e5\u5831\u5b50\u9801\u751f\u6548 *\/\nbody.parent-pageid-7356 .fusion-page-title-bar,\nbody.parent-pageid-7356 .fusion-page-title-row,\nbody.parent-pageid-7356 .fusion-page-title-wrapper {\n  display: none !important;\n  height: 0 !important;\n  padding: 0 !important;\n  margin: 0 !important;\n}\nbody.parent-pageid-7356 #main,\nbody.parent-pageid-7356 #content,\nbody.parent-pageid-7356 .fusion-row,\nbody.parent-pageid-7356 .post-content,\nbody.parent-pageid-7356 article.post {\n  padding-top: 0 !important;\n  margin-top: 0 !important;\n}\n\n\/* scoped(.wit-daily) *\/\n.wit-daily {\n  margin-left: calc((100% - 100vw) \/ 2);\n  margin-right: calc((100% - 100vw) \/ 2);\n  padding-left: calc((100vw - 100%) \/ 2);\n  padding-right: calc((100vw - 100%) \/ 2);\n  padding-top: 40px;\n  padding-bottom: 60px;\n  background: #0f0e0c;\n  color: #e8e3d8;\n  font-family: \"Noto Sans TC\", sans-serif;\n}\n.wit-daily .wrap { padding-left: 22px; padding-right: 22px; padding-top: 0; }\n.wit-daily a { color: inherit; }\n\/* \u5f37\u5236\u8986\u84cb Avada \u4e3b\u984c\u53ef\u80fd\u6ce8\u5165\u7684 blockquote \u767d\u5e95 *\/\n.wit-daily .c-counter blockquote,\n.wit-daily blockquote {\n  background: transparent !important;\n  background-color: transparent !important;\n  color: #e8e3d8 !important;\n  border-left: 3px solid #d4a574 !important;\n  padding: 6px 0 6px 16px !important;\n  font-style: italic !important;\n  margin: 0 !important;\n  box-shadow: none !important;\n}\n.wit-daily .c-counter blockquote::before,\n.wit-daily blockquote::before,\n.wit-daily blockquote::after { content: none !important; }\n<\/style>\n<div class=\"wit-daily\">\n\n<main class=\"wrap\">\n<header class=\"hdr\">\n<div class=\"hdr-date\"><time datetime=\"2026-04-28\">2026 \u5e74 04 \u6708 28 \u65e5<\/time><\/div>\n<h1>\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831<\/h1>\n<p class=\"hdr-sub\">\u5171\u6536\u9304 3 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 3 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/p>\n<\/header>\n<section aria-labelledby=\"sec-featured\">\n<h2 class=\"lbl\" id=\"sec-featured\">\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/h2>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#70AD47\">\u65b0\u8208\u7642\u6cd5<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/intellia-races-vivo-crispr-therapy-fda-after-phase-3-data-paint-compelling-picture\" rel=\"noopener nofollow\" target=\"_blank\">Intellia \u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u7b2c\u4e09\u671f\u6578\u64da\u5448\u73fe\u300c\u4ee4\u4eba\u4fe1\u670d\u300d\u7d50\u679c\u5f8c\u6025\u901f\u5411 FDA \u7533\u8acb\u4e0a\u5e02<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-04-28\" itemprop=\"datePublished\">2026-04-28<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cf\u25cf<\/span><span class=\"c-hype-tx\">5\/5 \u00b7 \u683c\u5c40\u91cd\u5851<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>NTLA<\/b> Intellia Therapeutics <span class=\"chg chg-down\">\u25bc4.33% $13.04<\/span><\/span><span class=\"stk stk-us\"><b>CRSP<\/b> CRISPR Therapeutics <span class=\"chg chg-up\">\u25b24.52% $50.99<\/span><\/span><span class=\"stk stk-us\"><b>EDIT<\/b> Editas Medicine <span class=\"chg chg-down\">\u25bc0.69% $2.89<\/span><\/span><span class=\"stk stk-other\"><b>3176<\/b> \u57fa\u4e9e\u751f\u6280 <span class=\"chg chg-down\">\u25bc2.85% $34.05<\/span><\/span><span class=\"stk stk-us\"><b>REGN<\/b> Regeneron <span class=\"chg chg-down\">\u25bc0.95% $744.44<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Intellia \u7684\u5728\u9ad4\u5167 CRISPR \u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u5728\u7b2c\u4e09\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\u5c55\u73fe\u4ee4\u4eba\u4fe1\u670d\u7684\u7642\u6548\u6578\u64da\uff0c\u516c\u53f8\u6b63\u52a0\u901f\u5411 FDA \u63d0\u4ea4\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\u3002\u6b64\u9805\u7a81\u7834\u4ee3\u8868 CRISPR \u6280\u8853\u5f9e\u96e2\u9ad4\u7d30\u80de\u6cbb\u7642\u9081\u5411\u76f4\u63a5\u5728\u60a3\u8005\u9ad4\u5167\u9032\u884c\u57fa\u56e0\u7de8\u8f2f\u7684\u91cd\u8981\u91cc\u7a0b\u7891\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403 CRISPR \u6cbb\u7642\u5e02\u5834\u9810\u8a08\u5f9e 2023 \u5e74\u7684 28 \u5104\u7f8e\u5143\u6210\u9577\u81f3 2030 \u5e74\u7684 212 \u5104\u7f8e\u5143\uff0c\u5e74\u8907\u5408\u6210\u9577\u7387\u9054 33.2%\u3002\u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u82e5\u6210\u529f\u4e0a\u5e02\uff0c\u55ae\u4e00\u7642\u7a0b\u5b9a\u50f9\u53ef\u80fd\u9054 100-200 \u842c\u7f8e\u5143\uff0c\u9060\u9ad8\u65bc\u73fe\u6709\u96e2\u9ad4 CAR-T \u7642\u6cd5\u7684 30-40 \u842c\u7f8e\u5143\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Intellia \u7684\u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u82e5\u7372 FDA \u6838\u51c6\uff0c\u5c07\u6210\u70ba\u5168\u7403\u9996\u500b\u76f4\u63a5\u5728\u60a3\u8005\u9ad4\u5167\u9032\u884c\u57fa\u56e0\u7de8\u8f2f\u7684\u5546\u696d\u5316\u6cbb\u7642\u65b9\u6848\uff0c\u5fb9\u5e95\u6539\u8b8a\u57fa\u56e0\u7642\u6cd5\u7684\u6cbb\u7642\u6a21\u5f0f\u3002\u76f8\u8f03\u65bc\u73fe\u6709\u9700\u53d6\u51fa\u7d30\u80de\u9032\u884c\u9ad4\u5916\u7de8\u8f2f\u518d\u56de\u8f38\u7684\u8907\u96dc\u6d41\u7a0b\uff0c\u5728\u9ad4\u5167\u7de8\u8f2f\u5927\u5e45\u7c21\u5316\u6cbb\u7642\u7a0b\u5e8f\u4e26\u964d\u4f4e\u611f\u67d3\u98a8\u96aa\uff0c\u6709\u671b\u64f4\u5927\u9069\u61c9\u75c7\u7bc4\u570d\u81f3\u66f4\u591a\u907a\u50b3\u6027\u75be\u75c5\u3002\u6b64\u6280\u8853\u7a81\u7834\u5c07\u91cd\u65b0\u5b9a\u7fa9\u7cbe\u6e96\u91ab\u7642\u7684\u6a19\u6e96\uff0c\u4e26\u70ba CRISPR \u7522\u696d\u5e36\u4f86\u4f30\u503c\u91cd\u4f30\u6a5f\u6703\u3002\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u76f8\u95dc\u516c\u53f8\u5982\u57fa\u4e9e\u751f\u6280\u4e5f\u53ef\u80fd\u53d7\u60e0\u65bc\u6280\u8853\u5e73\u53f0\u50f9\u503c\u63d0\u5347\u7684\u5916\u6ea2\u6548\u61c9\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u5728\u9ad4\u5167 CRISPR \u7de8\u8f2f\u96d6\u5177\u9769\u547d\u6027\u6f5b\u529b\uff0c\u4f46\u5b89\u5168\u6027\u7591\u616e\u4ecd\u672a\u5b8c\u5168\u6d88\u9664\uff0c\u5305\u62ec\u812b\u9776\u6548\u61c9\u3001\u514d\u75ab\u53cd\u61c9\u3001\u4ee5\u53ca\u9577\u671f\u57fa\u56e0\u4fee\u98fe\u7684\u672a\u77e5\u98a8\u96aa\uff0cFDA \u5be9\u67e5\u53ef\u80fd\u6bd4\u9810\u671f\u56b4\u683c\u4e14\u8017\u6642\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Intellia \u6b63\u5f0f\u5411 FDA \u63d0\u4ea4 BLA \u7533\u8acb\u6642\u7a0b<\/li><li>\u7b2c\u4e09\u671f\u8a66\u9a57\u5b8c\u6574\u6578\u64da\u767c\u8868\u8207\u5b89\u5168\u6027\u7d30\u7bc0<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>FDA \u512a\u5148\u5be9\u67e5\u8cc7\u683c\u8a8d\u5b9a\u8207\u5be9\u67e5\u6642\u7a0b<\/li><li>\u7af6\u722d\u5c0d\u624b CRISPR Therapeutics \u5728\u9ad4\u5167\u7642\u6cd5\u9032\u5c55<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u5728\u9ad4\u5167 CRISPR \u6280\u8853\u5e73\u53f0\u5411\u5176\u4ed6\u75be\u75c5\u9818\u57df\u64f4\u5c55<\/li><li>\u5168\u7403\u76e3\u7ba1\u6a5f\u69cb\u5c0d\u5728\u9ad4\u5167\u57fa\u56e0\u7de8\u8f2f\u7684\u9577\u671f\u5b89\u5168\u6027\u6a19\u6e96\u5236\u5b9a<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u8207\u73fe\u6709\u57fa\u56e0\u6cbb\u7642\u6709\u4ec0\u9ebc\u4e0d\u540c\uff1f<\/summary><p>\u5728\u9ad4\u5167 CRISPR \u76f4\u63a5\u5728\u60a3\u8005\u9ad4\u5167\u9032\u884c\u57fa\u56e0\u7de8\u8f2f\uff0c\u7121\u9700\u53d6\u51fa\u7d30\u80de\u9ad4\u5916\u8655\u7406\uff0c\u5927\u5e45\u7c21\u5316\u6cbb\u7642\u6d41\u7a0b\u4e26\u964d\u4f4e\u611f\u67d3\u98a8\u96aa\uff0c\u4f46\u5b89\u5168\u6027\u8981\u6c42\u66f4\u9ad8\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u9805\u6280\u8853\u7a81\u7834\u5c0d CRISPR \u7522\u696d\u4f30\u503c\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f<\/summary><p>\u5728\u9ad4\u5167 CRISPR \u82e5\u6210\u529f\u5546\u696d\u5316\uff0c\u5c07\u958b\u555f\u66f4\u5ee3\u6cdb\u7684\u6cbb\u7642\u61c9\u7528\u9818\u57df\uff0c\u9810\u671f\u63a8\u5347\u6574\u9ad4 CRISPR \u6cbb\u7642\u5e02\u5834\u5f9e 2023 \u5e74 28 \u5104\u7f8e\u5143\u5feb\u901f\u6210\u9577\u81f3 2030 \u5e74 212 \u5104\u7f8e\u5143\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u53f0\u7063\u751f\u6280\u516c\u53f8\u80fd\u5f9e\u9019\u6ce2 CRISPR \u71b1\u6f6e\u4e2d\u53d7\u76ca\u55ce\uff1f<\/summary><p>\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u76f8\u95dc\u516c\u53f8\u5982\u57fa\u4e9e\u751f\u6280\u53ef\u80fd\u53d7\u60e0\u65bc CRISPR \u6280\u8853\u5e73\u53f0\u50f9\u503c\u91cd\u4f30\uff0c\u4f46\u4e3b\u8981\u4ecd\u9700\u900f\u904e\u6280\u8853\u6388\u6b0a\u6216\u5408\u4f5c\u958b\u767c\u6a21\u5f0f\u53c3\u8207\u570b\u969b\u5e02\u5834\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/intellia-races-vivo-crispr-therapy-fda-after-phase-3-data-paint-compelling-picture\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#70AD47\">\u65b0\u8208\u7642\u6cd5<\/span>\n<span class=\"c-snt s-dn\">\u25bc \u504f\u7a7a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/astellas-thins-early-pipeline-swaps-out-struggling-rare-disease-gene-therapy\" rel=\"noopener nofollow\" target=\"_blank\">Astellas \u7cbe\u7c21\u65e9\u671f\u7522\u54c1\u7dda\uff0c\u6dd8\u6c70\u8868\u73fe\u4e0d\u4f73\u7684\u7f55\u898b\u75be\u75c5\u57fa\u56e0\u7642\u6cd5<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-04-28\" itemprop=\"datePublished\">2026-04-28<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-other\"><b>4503<\/b> Astellas Pharma <span class=\"chg chg-down\">\u25bc2.70% $2321.0<\/span><\/span><span class=\"stk stk-us\"><b>BMRN<\/b> BioMarin <span class=\"chg chg-up\">\u25b21.18% $53.81<\/span><\/span><span class=\"stk stk-us\"><b>SRPT<\/b> Sarepta Therapeutics <span class=\"chg chg-up\">\u25b23.35% $20.98<\/span><\/span><span class=\"stk stk-other\"><b>4726<\/b> \u6c38\u6615\u751f\u91ab <span class=\"chg chg-up\">\u25b20.87% $29.0<\/span><\/span><span class=\"stk stk-other\"><b>4128<\/b> \u4e2d\u5929\u751f\u6280 <span class=\"chg chg-up\">\u25b20.32% $15.75<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u65e5\u672c\u88fd\u85e5\u5de8\u982d Astellas \u6c7a\u5b9a\u7cbe\u7c21\u65e9\u671f\u7814\u767c\u7ba1\u7dda\uff0c\u7d42\u6b62\u591a\u9805\u8868\u73fe\u4e0d\u4f73\u7684\u7f55\u898b\u75be\u75c5\u57fa\u56e0\u6cbb\u7642\u5c08\u6848\u3002\u9019\u53cd\u6620\u57fa\u56e0\u6cbb\u7642\u9818\u57df\u7684\u9ad8\u6280\u8853\u9580\u6abb\u8207\u5546\u696d\u5316\u6311\u6230\uff0c\u5373\u4f7f\u662f\u8cc7\u91d1\u5145\u6c9b\u7684\u5927\u578b\u85e5\u5ee0\u4e5f\u9762\u81e8\u7814\u767c\u6548\u7387\u58d3\u529b\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403\u57fa\u56e0\u6cbb\u7642\u5e02\u5834\u96d6\u9810\u671f\u5f9e 2023 \u5e74 87 \u5104\u7f8e\u5143\u6210\u9577\u81f3 2030 \u5e74 407 \u5104\u7f8e\u5143\uff0c\u4f46\u6210\u529f\u7387\u50c5\u7d04 13.6%\uff0c\u9060\u4f4e\u65bc\u50b3\u7d71\u5c0f\u5206\u5b50\u85e5\u7269\u7684 20-25%\u3002\u55ae\u4e00\u57fa\u56e0\u6cbb\u7642\u5c08\u6848\u5e73\u5747\u958b\u767c\u6210\u672c\u8d85\u904e 10 \u5104\u7f8e\u5143\uff0c\u958b\u767c\u6642\u7a0b\u9577\u9054 10-15 \u5e74\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Astellas \u7d42\u6b62\u57fa\u56e0\u6cbb\u7642\u5c08\u6848\u986f\u793a\u5373\u4f7f\u662f\u8ca1\u529b\u96c4\u539a\u7684\u570b\u969b\u85e5\u5ee0\uff0c\u4e5f\u958b\u59cb\u66f4\u5be9\u614e\u8a55\u4f30\u57fa\u56e0\u6cbb\u7642\u7684\u6295\u8cc7\u5831\u916c\u7387\u8207\u6280\u8853\u53ef\u884c\u6027\u3002\u57fa\u56e0\u6cbb\u7642\u96d6\u5177\u9f90\u5927\u5e02\u5834\u6f5b\u529b\uff0c\u4f46\u88fd\u9020\u8907\u96dc\u5ea6\u9ad8\u3001\u76e3\u7ba1\u8981\u6c42\u56b4\u683c\u3001\u60a3\u8005\u65cf\u7fa4\u6709\u9650\u7b49\u7d50\u69cb\u6027\u6311\u6230\uff0c\u8feb\u4f7f\u85e5\u5ee0\u91cd\u65b0\u6aa2\u8996\u8cc7\u6e90\u914d\u7f6e\u7b56\u7565\u3002\u6b64\u8da8\u52e2\u53ef\u80fd\u5c0e\u81f4\u7522\u696d\u6574\u4f75\u52a0\u901f\uff0c\u6280\u8853\u80fd\u529b\u4e0d\u8db3\u7684\u4e2d\u5c0f\u578b\u57fa\u56e0\u6cbb\u7642\u516c\u53f8\u9762\u81e8\u66f4\u5927\u751f\u5b58\u58d3\u529b\u3002\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u65b0\u5275\u5982\u6c38\u6615\u751f\u91ab\u3001\u4e2d\u5929\u751f\u6280\u9700\u66f4\u5c08\u6ce8\u65bc\u5dee\u7570\u5316\u6280\u8853\u5e73\u53f0\u5efa\u69cb\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u5927\u578b\u85e5\u5ee0\u9000\u51fa\u7279\u5b9a\u57fa\u56e0\u6cbb\u7642\u9818\u57df\uff0c\u53cd\u800c\u70ba\u5c08\u7cbe\u6280\u8853\u7684\u751f\u6280\u65b0\u5275\u516c\u53f8\u5275\u9020\u66f4\u591a\u6388\u6b0a\u5408\u4f5c\u6a5f\u6703\uff0c\u907f\u514d\u8207\u8cc7\u6e90\u96c4\u539a\u7684\u5de8\u982d\u76f4\u63a5\u7af6\u722d\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>\u5176\u4ed6\u570b\u969b\u85e5\u5ee0\u662f\u5426\u8ddf\u9032\u8abf\u6574\u57fa\u56e0\u6cbb\u7642\u6295\u8cc7\u7b56\u7565<\/li><li>\u88ab\u7d42\u6b62\u5c08\u6848\u7684\u6280\u8853\u8cc7\u7522\u5f8c\u7e8c\u8655\u7f6e\u65b9\u5f0f<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u57fa\u56e0\u6cbb\u7642 CDMO \u4ee3\u5de5\u9700\u6c42\u8b8a\u5316\u8da8\u52e2<\/li><li>\u5c08\u7cbe\u578b\u57fa\u56e0\u6cbb\u7642\u516c\u53f8\u80a1\u50f9\u8207\u878d\u8cc7\u74b0\u5883\u8abf\u6574<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u57fa\u56e0\u6cbb\u7642\u7522\u696d\u6280\u8853\u6a19\u6e96\u8207\u5546\u696d\u6a21\u5f0f\u91cd\u65b0\u6d17\u724c<\/li><li>\u76e3\u7ba1\u6a5f\u69cb\u5c0d\u57fa\u56e0\u6cbb\u7642\u5be9\u67e5\u6a19\u6e96\u7684\u9577\u671f\u6f14\u9032<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u70ba\u4ec0\u9ebc\u9023 Astellas \u9019\u6a23\u7684\u5927\u85e5\u5ee0\u90fd\u8981\u653e\u68c4\u57fa\u56e0\u6cbb\u7642\u5c08\u6848\uff1f<\/summary><p>\u57fa\u56e0\u6cbb\u7642\u958b\u767c\u6210\u672c\u8d85\u904e 10 \u5104\u7f8e\u5143\u3001\u6210\u529f\u7387\u50c5 13.6%\uff0c\u52a0\u4e0a\u88fd\u9020\u8907\u96dc\u5ea6\u9ad8\u8207\u76e3\u7ba1\u56b4\u683c\uff0c\u5373\u4f7f\u5927\u85e5\u5ee0\u4e5f\u9700\u91cd\u65b0\u8a55\u4f30\u6295\u8cc7\u6548\u76ca\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u5c0d\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u7522\u696d\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f<\/summary><p>\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u516c\u53f8\u5982\u6c38\u6615\u751f\u91ab\u3001\u4e2d\u5929\u751f\u6280\u9762\u81e8\u66f4\u5927\u7af6\u722d\u58d3\u529b\uff0c\u4f46\u4e5f\u6709\u6a5f\u6703\u627f\u63a5\u570b\u969b\u85e5\u5ee0\u91cb\u51fa\u7684\u6280\u8853\u8cc7\u7522\u6216\u4ee3\u5de5\u8a02\u55ae\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u57fa\u56e0\u6cbb\u7642\u5e02\u5834\u524d\u666f\u662f\u5426\u56e0\u6b64\u8f49\u70ba\u60b2\u89c0\uff1f<\/summary><p>\u6574\u9ad4\u5e02\u5834\u4ecd\u9810\u671f\u6210\u9577\u81f3 2030 \u5e74 407 \u5104\u7f8e\u5143\uff0c\u4f46\u7522\u696d\u5c07\u671d\u5411\u6280\u8853\u5c08\u7cbe\u5316\u8207\u5e73\u53f0\u6574\u4f75\u65b9\u5411\u767c\u5c55\uff0c\u6dd8\u6c70\u6280\u8853\u80fd\u529b\u4e0d\u8db3\u7684\u696d\u8005\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/astellas-thins-early-pipeline-swaps-out-struggling-rare-disease-gene-therapy\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-nu\">\u25ac \u4e2d\u6027<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/ligand-snaps-fellow-biotech-royalty-aggregator-xoma-739m\" rel=\"noopener nofollow\" target=\"_blank\">Ligand \u4ee5 7.39 \u5104\u7f8e\u5143\u6536\u8cfc\u540c\u696d\u751f\u6280\u6b0a\u5229\u91d1\u805a\u5408\u5546 Xoma<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-04-28\" itemprop=\"datePublished\">2026-04-28<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cb\u25cb\u25cb<\/span><span class=\"c-hype-tx\">2\/5 \u00b7 \u6b21\u8981\u52d5\u614b<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>LGND<\/b> Ligand Pharmaceuticals <span class=\"chg chg-up\">\u25b24.55% $241.79<\/span><\/span><span class=\"stk stk-us\"><b>XOMA<\/b> Xoma Corporation <span class=\"chg chg-up\">\u25b210.74% $41.97<\/span><\/span><span class=\"stk stk-us\"><b>RPRX<\/b> Royalty Pharma <span class=\"chg chg-up\">\u25b20.55% $49.65<\/span><\/span><span class=\"stk stk-other\"><b>4743<\/b> \u5408\u4e00\u751f\u6280 <span class=\"chg chg-flat\">\u25000.00% $52.5<\/span><\/span><span class=\"stk stk-other\"><b>4174<\/b> \u6d69\u9f0e\u751f\u6280 <span class=\"chg chg-flat\">\u25000.00% $32.05<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u751f\u6280\u6b0a\u5229\u91d1\u805a\u5408\u516c\u53f8 Ligand \u4ee5 7.39 \u5104\u7f8e\u5143\u6536\u8cfc\u540c\u696d\u7af6\u722d\u5c0d\u624b Xoma\uff0c\u64f4\u5927\u5176\u667a\u6167\u8ca1\u7522\u6b0a\u7d44\u5408\u898f\u6a21\u3002\u6b64\u4f75\u8cfc\u6848\u53cd\u6620\u751f\u6280\u7522\u696d\u6b0a\u5229\u91d1\u6536\u76ca\u6a21\u5f0f\u65e5\u8da8\u6210\u719f\uff0c\u5c08\u696d\u6295\u8cc7\u6a5f\u69cb\u900f\u904e\u6574\u4f75\u63d0\u5347\u8b70\u50f9\u80fd\u529b\u8207\u73fe\u91d1\u6d41\u7a69\u5b9a\u6027\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403\u751f\u6280\u6b0a\u5229\u91d1\u5e02\u5834\u898f\u6a21\u7d04 180 \u5104\u7f8e\u5143\uff0cRoyalty Pharma \u4ee5 200 \u5104\u7f8e\u5143\u8cc7\u7522\u898f\u6a21\u5c45\u9996\uff0cLigand \u4f75\u8cfc Xoma \u5f8c\u8cc7\u7522\u7d44\u5408\u5c07\u8d85\u904e 30 \u5104\u7f8e\u5143\u3002\u751f\u6280\u6b0a\u5229\u91d1\u6295\u8cc7\u5831\u916c\u7387\u901a\u5e38\u4ecb\u65bc 8-12%\uff0c\u73fe\u91d1\u6d41\u671f\u9593\u53ef\u9054 10-20 \u5e74\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Ligand \u4f75\u8cfc Xoma \u986f\u793a\u751f\u6280\u6b0a\u5229\u91d1\u805a\u5408\u6a21\u5f0f\u5df2\u9032\u5165\u6210\u719f\u6574\u4f75\u671f\uff0c\u900f\u904e\u898f\u6a21\u7d93\u6fdf\u964d\u4f4e\u7ba1\u7406\u6210\u672c\u4e26\u63d0\u5347\u8ac7\u5224\u7c4c\u78bc\u3002\u6b0a\u5229\u91d1\u805a\u5408\u5546\u70ba\u65e9\u671f\u751f\u6280\u516c\u53f8\u63d0\u4f9b\u975e\u7a00\u91cb\u6027\u8cc7\u91d1\u4f86\u6e90\uff0c\u5728\u7576\u524d\u878d\u8cc7\u74b0\u5883\u7dca\u7e2e\u4e0b\u626e\u6f14\u91cd\u8981\u89d2\u8272\uff0c\u4f46\u4e5f\u53cd\u6620\u751f\u6280\u5275\u65b0\u50f9\u503c\u93c8\u7684\u91d1\u878d\u5316\u8da8\u52e2\u3002\u6b64\u6a21\u5f0f\u5c0d\u53f0\u7063\u751f\u6280\u516c\u53f8\u800c\u8a00\u662f\u96d9\u9762\u5203\uff1a\u4e00\u65b9\u9762\u63d0\u4f9b\u8cc7\u91d1\u53d6\u5f97\u7ba1\u9053\uff0c\u53e6\u4e00\u65b9\u9762\u53ef\u80fd\u58d3\u7e2e\u9577\u671f\u7372\u5229\u7a7a\u9593\u3002\u96a8\u8457\u805a\u5408\u5546\u8b70\u50f9\u80fd\u529b\u589e\u5f37\uff0c\u672a\u4f86\u6b0a\u5229\u91d1\u4ea4\u6613\u689d\u4ef6\u53ef\u80fd\u66f4\u504f\u5411\u8cb7\u65b9\u5e02\u5834\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u6b0a\u5229\u91d1\u805a\u5408\u6a21\u5f0f\u96d6\u63d0\u4f9b\u7a69\u5b9a\u73fe\u91d1\u6d41\uff0c\u4f46\u904e\u5ea6\u4f9d\u8cf4\u65e2\u6709\u5c08\u5229\u7d44\u5408\uff0c\u7f3a\u4e4f\u5275\u65b0\u9a45\u52d5\u529b\uff0c\u5728\u751f\u6280\u7522\u696d\u5feb\u901f\u6f14\u9032\u4e0b\u53ef\u80fd\u9762\u81e8\u6280\u8853\u904e\u6642\u98a8\u96aa\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>\u4f75\u8cfc\u6848\u76e3\u7ba1\u5be9\u67e5\u9032\u7a0b\u8207\u5b8c\u6210\u6642\u7a0b<\/li><li>Ligand \u6574\u4f75\u5f8c\u6b0a\u5229\u91d1\u7d44\u5408\u8abf\u6574\u7b56\u7565<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u5176\u4ed6\u6b0a\u5229\u91d1\u805a\u5408\u5546\u8ddf\u9032\u6574\u4f75\u52d5\u4f5c<\/li><li>\u53f0\u7063\u751f\u6280\u516c\u53f8\u6b0a\u5229\u91d1\u4ea4\u6613\u689d\u4ef6\u8b8a\u5316<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u751f\u6280\u6b0a\u5229\u91d1\u5e02\u5834\u96c6\u4e2d\u5ea6\u63d0\u5347\u5c0d\u5275\u65b0\u751f\u614b\u5f71\u97ff<\/li><li>\u65b0\u8208\u6280\u8853\u5e73\u53f0\u5c0d\u50b3\u7d71\u6b0a\u5229\u91d1\u6a21\u5f0f\u7684\u885d\u64ca<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u751f\u6280\u6b0a\u5229\u91d1\u805a\u5408\u5546\u7684\u5546\u696d\u6a21\u5f0f\u662f\u4ec0\u9ebc\uff1f<\/summary><p>\u900f\u904e\u8cfc\u8cb7\u751f\u6280\u516c\u53f8\u7684\u85e5\u7269\u6b0a\u5229\u91d1\u6536\u76ca\u6b0a\uff0c\u63d0\u4f9b\u524d\u671f\u8cc7\u91d1\u5354\u52a9\u7814\u767c\uff0c\u518d\u5f9e\u5f8c\u7e8c\u7522\u54c1\u92b7\u552e\u4e2d\u7372\u5f97\u9577\u671f\u7a69\u5b9a\u73fe\u91d1\u6d41\u5831\u916c\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u6b21\u4f75\u8cfc\u5c0d\u53f0\u7063\u751f\u6280\u516c\u53f8\u6709\u4ec0\u9ebc\u610f\u7fa9\uff1f<\/summary><p>\u6b0a\u5229\u91d1\u805a\u5408\u5546\u6574\u4f75\u5f8c\u8b70\u50f9\u80fd\u529b\u589e\u5f37\uff0c\u53f0\u7063\u751f\u6280\u516c\u53f8\u5982\u5408\u4e00\u3001\u6d69\u9f0e\u5728\u6b0a\u5229\u91d1\u4ea4\u6613\u6642\u53ef\u80fd\u9762\u81e8\u66f4\u56b4\u683c\u7684\u689d\u4ef6\u8ac7\u5224\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u70ba\u4ec0\u9ebc Ligand \u8981\u82b1 7.39 \u5104\u7f8e\u5143\u4f75\u8cfc\u7af6\u722d\u5c0d\u624b\uff1f<\/summary><p>\u900f\u904e\u6574\u4f75\u64f4\u5927\u6b0a\u5229\u91d1\u7d44\u5408\u898f\u6a21\u3001\u964d\u4f4e\u7ba1\u7406\u6210\u672c\uff0c\u4e26\u63d0\u5347\u8207\u751f\u6280\u516c\u53f8\u8ac7\u5224\u6642\u7684\u7c4c\u78bc\uff0c\u5275\u9020\u898f\u6a21\u7d93\u6fdf\u6548\u76ca\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/ligand-snaps-fellow-biotech-royalty-aggregator-xoma-739m\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<\/section>\n<section aria-labelledby=\"sec-briefs\">\n<h2 class=\"lbl\" id=\"sec-briefs\">\u4eca\u65e5\u5feb\u8a0a<\/h2>\n<ul class=\"briefs\" style=\"list-style:none\">\n<\/ul>\n<\/section>\n<section aria-labelledby=\"sec-stats\" class=\"stats\" style=\"margin-top:48px\">\n<h2 class=\"lbl\" id=\"sec-stats\" style=\"font-size:16px;border-bottom-width:1px\">\u5206\u985e\u7d71\u8a08<\/h2>\n<div class=\"st\"><div class=\"st-bar\" style=\"width:33.33333333333333%;background:#4472C4\"><\/div><span class=\"st-lb\">\u85e5\u7269<\/span><span class=\"st-ct\">1<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:66.66666666666666%;background:#70AD47\"><\/div><span class=\"st-lb\">\u65b0\u8208\u7642\u6cd5<\/span><span class=\"st-ct\">2<\/span><\/div>\n<\/section>\n<!-- footer \u5df2\u79fb\u9664(v2.14.0) -->\n<\/main>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2026 \u5e74 04 \u6708 28 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 \u5171\u6536\u9304 3 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 3 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790 \u7cbe\u9078 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":7356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"rank_math_title":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-04-28\uff5cIntellia \u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u7b2c\u4e09\u671f\u6578","rank_math_description":"2026 \u5e74 04 \u6708 28 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aIntellia \u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u7b2c\u4e09\u671f\u6578\u64da\u5448\u73fe\u300c\u4ee4\u4eba\u4fe1\u670d\u300d\u3001Astellas \u7cbe\u7c21\u65e9\u671f\u7522\u54c1\u7dda\uff0c\u6dd8\u6c70\u8868\u73fe\u4e0d\u4f73\u7684\u7f55\u898b\u75be\u75c5\u57fa\u56e0\u7642\u6cd5\u3002\u5171\u6536\u9304 3 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002","rank_math_focus_keyword":"\u751f\u91ab\u5927\u5065\u5eb7","rank_math_robots":"","daily_schema_jsonld":"[\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"CollectionPage\",\n    \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-04-28\uff5cIntellia \u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u7b2c\u4e09\u671f\u6578\",\n    \"description\": \"2026 \u5e74 04 \u6708 28 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aIntellia \u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u7b2c\u4e09\u671f\u6578\u64da\u5448\u73fe\u300c\u4ee4\u4eba\u4fe1\u670d\u300d\u3001Astellas \u7cbe\u7c21\u65e9\u671f\u7522\u54c1\u7dda\uff0c\u6dd8\u6c70\u8868\u73fe\u4e0d\u4f73\u7684\u7f55\u898b\u75be\u75c5\u57fa\u56e0\u7642\u6cd5\u3002\u5171\u6536\u9304 3 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002\",\n    \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-28\",\n    \"datePublished\": \"2026-04-28\",\n    \"inLanguage\": \"zh-TW\",\n    \"publisher\": {\n      \"@type\": \"Organization\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n      }\n    },\n    \"isPartOf\": {\n      \"@type\": \"WebSite\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"url\": \"https:\/\/witology.com.tw\"\n    },\n    \"hasPart\": [\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Intellia \u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u7b2c\u4e09\u671f\u6578\u64da\u5448\u73fe\u300c\u4ee4\u4eba\u4fe1\u670d\u300d\u7d50\u679c\u5f8c\u6025\u901f\u5411 FDA \u7533\u8acb\u4e0a\u5e02\",\n        \"datePublished\": \"2026-04-28\",\n        \"dateModified\": \"2026-04-28\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-04-28#article-1\"\n        },\n        \"description\": \"Intellia \u7684\u5728\u9ad4\u5167 CRISPR \u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u5728\u7b2c\u4e09\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\u5c55\u73fe\u4ee4\u4eba\u4fe1\u670d\u7684\u7642\u6548\u6578\u64da\uff0c\u516c\u53f8\u6b63\u52a0\u901f\u5411 FDA \u63d0\u4ea4\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\u3002\u6b64\u9805\u7a81\u7834\u4ee3\u8868 CRISPR \u6280\u8853\u5f9e\u96e2\u9ad4\u7d30\u80de\u6cbb\u7642\u9081\u5411\u76f4\u63a5\u5728\u60a3\u8005\u9ad4\u5167\u9032\u884c\u57fa\u56e0\u7de8\u8f2f\u7684\u91cd\u8981\u91cc\u7a0b\u7891\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-28#article-1\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/intellia-races-vivo-crispr-therapy-fda-after-phase-3-data-paint-compelling-picture\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Intellia Therapeutics\",\n            \"tickerSymbol\": \"NTLA\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"CRISPR Therapeutics\",\n            \"tickerSymbol\": \"CRSP\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Editas Medicine\",\n            \"tickerSymbol\": \"EDIT\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u57fa\u4e9e\u751f\u6280\",\n            \"tickerSymbol\": \"3176\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Regeneron\",\n            \"tickerSymbol\": \"REGN\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Astellas \u7cbe\u7c21\u65e9\u671f\u7522\u54c1\u7dda\uff0c\u6dd8\u6c70\u8868\u73fe\u4e0d\u4f73\u7684\u7f55\u898b\u75be\u75c5\u57fa\u56e0\u7642\u6cd5\",\n        \"datePublished\": \"2026-04-28\",\n        \"dateModified\": \"2026-04-28\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-04-28#article-2\"\n        },\n        \"description\": \"\u65e5\u672c\u88fd\u85e5\u5de8\u982d Astellas \u6c7a\u5b9a\u7cbe\u7c21\u65e9\u671f\u7814\u767c\u7ba1\u7dda\uff0c\u7d42\u6b62\u591a\u9805\u8868\u73fe\u4e0d\u4f73\u7684\u7f55\u898b\u75be\u75c5\u57fa\u56e0\u6cbb\u7642\u5c08\u6848\u3002\u9019\u53cd\u6620\u57fa\u56e0\u6cbb\u7642\u9818\u57df\u7684\u9ad8\u6280\u8853\u9580\u6abb\u8207\u5546\u696d\u5316\u6311\u6230\uff0c\u5373\u4f7f\u662f\u8cc7\u91d1\u5145\u6c9b\u7684\u5927\u578b\u85e5\u5ee0\u4e5f\u9762\u81e8\u7814\u767c\u6548\u7387\u58d3\u529b\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-28#article-2\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/astellas-thins-early-pipeline-swaps-out-struggling-rare-disease-gene-therapy\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Astellas Pharma\",\n            \"tickerSymbol\": \"4503\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"BioMarin\",\n            \"tickerSymbol\": \"BMRN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Sarepta Therapeutics\",\n            \"tickerSymbol\": \"SRPT\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u6c38\u6615\u751f\u91ab\",\n            \"tickerSymbol\": \"4726\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4e2d\u5929\u751f\u6280\",\n            \"tickerSymbol\": \"4128\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Ligand \u4ee5 7.39 \u5104\u7f8e\u5143\u6536\u8cfc\u540c\u696d\u751f\u6280\u6b0a\u5229\u91d1\u805a\u5408\u5546 Xoma\",\n        \"datePublished\": \"2026-04-28\",\n        \"dateModified\": \"2026-04-28\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-04-28#article-3\"\n        },\n        \"description\": \"\u751f\u6280\u6b0a\u5229\u91d1\u805a\u5408\u516c\u53f8 Ligand \u4ee5 7.39 \u5104\u7f8e\u5143\u6536\u8cfc\u540c\u696d\u7af6\u722d\u5c0d\u624b Xoma\uff0c\u64f4\u5927\u5176\u667a\u6167\u8ca1\u7522\u6b0a\u7d44\u5408\u898f\u6a21\u3002\u6b64\u4f75\u8cfc\u6848\u53cd\u6620\u751f\u6280\u7522\u696d\u6b0a\u5229\u91d1\u6536\u76ca\u6a21\u5f0f\u65e5\u8da8\u6210\u719f\uff0c\u5c08\u696d\u6295\u8cc7\u6a5f\u69cb\u900f\u904e\u6574\u4f75\u63d0\u5347\u8b70\u50f9\u80fd\u529b\u8207\u73fe\u91d1\u6d41\u7a69\u5b9a\u6027\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-28#article-3\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/pharma\/ligand-snaps-fellow-biotech-royalty-aggregator-xoma-739m\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Ligand Pharmaceuticals\",\n            \"tickerSymbol\": \"LGND\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Xoma Corporation\",\n            \"tickerSymbol\": \"XOMA\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Royalty Pharma\",\n            \"tickerSymbol\": \"RPRX\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u5408\u4e00\u751f\u6280\",\n            \"tickerSymbol\": \"4743\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u6d69\u9f0e\u751f\u6280\",\n            \"tickerSymbol\": \"4174\"\n          }\n        ]\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"BreadcrumbList\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 1,\n        \"name\": \"\u9996\u9801\",\n        \"item\": \"https:\/\/witology.com.tw\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 2,\n        \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 3,\n        \"name\": \"2026-04-28\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\/2026-04-28\"\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"FAQPage\",\n    \"mainEntity\": [\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u5728\u9ad4\u5167 CRISPR \u7642\u6cd5\u8207\u73fe\u6709\u57fa\u56e0\u6cbb\u7642\u6709\u4ec0\u9ebc\u4e0d\u540c\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u5728\u9ad4\u5167 CRISPR \u76f4\u63a5\u5728\u60a3\u8005\u9ad4\u5167\u9032\u884c\u57fa\u56e0\u7de8\u8f2f\uff0c\u7121\u9700\u53d6\u51fa\u7d30\u80de\u9ad4\u5916\u8655\u7406\uff0c\u5927\u5e45\u7c21\u5316\u6cbb\u7642\u6d41\u7a0b\u4e26\u964d\u4f4e\u611f\u67d3\u98a8\u96aa\uff0c\u4f46\u5b89\u5168\u6027\u8981\u6c42\u66f4\u9ad8\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u9805\u6280\u8853\u7a81\u7834\u5c0d CRISPR \u7522\u696d\u4f30\u503c\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u5728\u9ad4\u5167 CRISPR \u82e5\u6210\u529f\u5546\u696d\u5316\uff0c\u5c07\u958b\u555f\u66f4\u5ee3\u6cdb\u7684\u6cbb\u7642\u61c9\u7528\u9818\u57df\uff0c\u9810\u671f\u63a8\u5347\u6574\u9ad4 CRISPR \u6cbb\u7642\u5e02\u5834\u5f9e 2023 \u5e74 28 \u5104\u7f8e\u5143\u5feb\u901f\u6210\u9577\u81f3 2030 \u5e74 212 \u5104\u7f8e\u5143\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u53f0\u7063\u751f\u6280\u516c\u53f8\u80fd\u5f9e\u9019\u6ce2 CRISPR \u71b1\u6f6e\u4e2d\u53d7\u76ca\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u76f8\u95dc\u516c\u53f8\u5982\u57fa\u4e9e\u751f\u6280\u53ef\u80fd\u53d7\u60e0\u65bc CRISPR \u6280\u8853\u5e73\u53f0\u50f9\u503c\u91cd\u4f30\uff0c\u4f46\u4e3b\u8981\u4ecd\u9700\u900f\u904e\u6280\u8853\u6388\u6b0a\u6216\u5408\u4f5c\u958b\u767c\u6a21\u5f0f\u53c3\u8207\u570b\u969b\u5e02\u5834\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u70ba\u4ec0\u9ebc\u9023 Astellas \u9019\u6a23\u7684\u5927\u85e5\u5ee0\u90fd\u8981\u653e\u68c4\u57fa\u56e0\u6cbb\u7642\u5c08\u6848\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u57fa\u56e0\u6cbb\u7642\u958b\u767c\u6210\u672c\u8d85\u904e 10 \u5104\u7f8e\u5143\u3001\u6210\u529f\u7387\u50c5 13.6%\uff0c\u52a0\u4e0a\u88fd\u9020\u8907\u96dc\u5ea6\u9ad8\u8207\u76e3\u7ba1\u56b4\u683c\uff0c\u5373\u4f7f\u5927\u85e5\u5ee0\u4e5f\u9700\u91cd\u65b0\u8a55\u4f30\u6295\u8cc7\u6548\u76ca\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u5c0d\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u7522\u696d\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53f0\u7063\u57fa\u56e0\u6cbb\u7642\u516c\u53f8\u5982\u6c38\u6615\u751f\u91ab\u3001\u4e2d\u5929\u751f\u6280\u9762\u81e8\u66f4\u5927\u7af6\u722d\u58d3\u529b\uff0c\u4f46\u4e5f\u6709\u6a5f\u6703\u627f\u63a5\u570b\u969b\u85e5\u5ee0\u91cb\u51fa\u7684\u6280\u8853\u8cc7\u7522\u6216\u4ee3\u5de5\u8a02\u55ae\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u57fa\u56e0\u6cbb\u7642\u5e02\u5834\u524d\u666f\u662f\u5426\u56e0\u6b64\u8f49\u70ba\u60b2\u89c0\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u6574\u9ad4\u5e02\u5834\u4ecd\u9810\u671f\u6210\u9577\u81f3 2030 \u5e74 407 \u5104\u7f8e\u5143\uff0c\u4f46\u7522\u696d\u5c07\u671d\u5411\u6280\u8853\u5c08\u7cbe\u5316\u8207\u5e73\u53f0\u6574\u4f75\u65b9\u5411\u767c\u5c55\uff0c\u6dd8\u6c70\u6280\u8853\u80fd\u529b\u4e0d\u8db3\u7684\u696d\u8005\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u751f\u6280\u6b0a\u5229\u91d1\u805a\u5408\u5546\u7684\u5546\u696d\u6a21\u5f0f\u662f\u4ec0\u9ebc\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u900f\u904e\u8cfc\u8cb7\u751f\u6280\u516c\u53f8\u7684\u85e5\u7269\u6b0a\u5229\u91d1\u6536\u76ca\u6b0a\uff0c\u63d0\u4f9b\u524d\u671f\u8cc7\u91d1\u5354\u52a9\u7814\u767c\uff0c\u518d\u5f9e\u5f8c\u7e8c\u7522\u54c1\u92b7\u552e\u4e2d\u7372\u5f97\u9577\u671f\u7a69\u5b9a\u73fe\u91d1\u6d41\u5831\u916c\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u6b21\u4f75\u8cfc\u5c0d\u53f0\u7063\u751f\u6280\u516c\u53f8\u6709\u4ec0\u9ebc\u610f\u7fa9\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u6b0a\u5229\u91d1\u805a\u5408\u5546\u6574\u4f75\u5f8c\u8b70\u50f9\u80fd\u529b\u589e\u5f37\uff0c\u53f0\u7063\u751f\u6280\u516c\u53f8\u5982\u5408\u4e00\u3001\u6d69\u9f0e\u5728\u6b0a\u5229\u91d1\u4ea4\u6613\u6642\u53ef\u80fd\u9762\u81e8\u66f4\u56b4\u683c\u7684\u689d\u4ef6\u8ac7\u5224\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u70ba\u4ec0\u9ebc Ligand \u8981\u82b1 7.39 \u5104\u7f8e\u5143\u4f75\u8cfc\u7af6\u722d\u5c0d\u624b\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u900f\u904e\u6574\u4f75\u64f4\u5927\u6b0a\u5229\u91d1\u7d44\u5408\u898f\u6a21\u3001\u964d\u4f4e\u7ba1\u7406\u6210\u672c\uff0c\u4e26\u63d0\u5347\u8207\u751f\u6280\u516c\u53f8\u8ac7\u5224\u6642\u7684\u7c4c\u78bc\uff0c\u5275\u9020\u898f\u6a21\u7d93\u6fdf\u6548\u76ca\u3002\"\n        }\n      }\n    ]\n  }\n]","daily_standalone_url":"","footnotes":""},"class_list":["post-7432","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/comments?post=7432"}],"version-history":[{"count":1,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7432\/revisions"}],"predecessor-version":[{"id":7441,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7432\/revisions\/7441"}],"up":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7356"}],"wp:attachment":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/media?parent=7432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}